Gastroenteropancreatico Tumors

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Gastroenteropancreatico Tumors trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT04086485

Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GE…

Background: A neuroendocrine tumor is a rare type of tumor. It comes from body cells called neuroendocrine cells. Sometimes, these tumors develop in the gastro…

United States56 participantsStarted 2022-10-03

Treatment: Lu-177-DOTATATE, Olaparib

Gastroenteropancreatico Tumors

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GE…

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GE…

All recent trials (1 shown)